Continuous glucose monitoring in cystic fibrosis – A practical guide

Christine L. Chan, Katie Larson Ode, Andrea Granados, Amir Moheet, Antoinette Moran, Shihab Hameed

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Our ability to monitor blood glucose levels has become increasingly accurate over the last few decades. Continuous glucose monitoring (CGM) technology now allows providers and patients the ability to monitor glucose levels retrospectively as well as in real-time for diabetes management. CGM also provides the ability to study glucose patterns and trends for insight into the pathophysiology and natural history of disease. CGM captures a more complete picture of glucose profiles than traditional measures of glycemia such as the hemoglobin A1c or self-monitoring of blood glucose levels. This article provides a review of the history of glucose monitoring, a review of the literature pertaining to CGM with a focus on studies in patients with cystic fibrosis, and discusses practical uses of CGM technology and its application for the evaluation and management of cystic fibrosis related diabetes.

Original languageEnglish
Pages (from-to)S25-S31
JournalJournal of Cystic Fibrosis
StatePublished - Oct 2019


  • Artificial pancreas
  • Continuous glucose monitoring
  • Cystic fibrosis related diabetes


Dive into the research topics of 'Continuous glucose monitoring in cystic fibrosis – A practical guide'. Together they form a unique fingerprint.

Cite this